Apremilast Regulates the Teff/Treg Balance to Ameliorate Uveitis via PI3K/AKT/FoxO1 Signaling Pathway

Autoimmune uveitis (AU), being one of the sight-threatening ocular inflammatory disorders, has been widely regarded by ophthalmologists and immunologists as a great challenge. Apremilast, a phosphodiesterase-4 inhibitor (PDE4i), which was approved by the U.S. Food and Drug Administration (FDA) for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuxi, Li, Zhuang, Li, He, Su, Wenru, Xie, Yanyan, Pan, Yuan, Chen, Xiaoqing, Liang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705241/
https://www.ncbi.nlm.nih.gov/pubmed/33281814
http://dx.doi.org/10.3389/fimmu.2020.581673

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705241/
https://www.ncbi.nlm.nih.gov/pubmed/33281814
http://dx.doi.org/10.3389/fimmu.2020.581673

Ejemplares similares